Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma

BACKGROUND: 1q21.3 amplification, which is frequently observed in metastatic melanoma, is associated with cancer progression. Interleukin enhancer‐binding factor 2 (ILF2) is located in the 1q21.3 amplified region, but its functional role or contribution to tumour aggressiveness in cutaneous melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoqing, Bustos, Matias A., Gross, Rebecca, Ramos, Romela Irene, Takeshima, Teh‐Ling, Mills, Gordon B., Yu, Qiang, Hoon, Dave S. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516365/
https://www.ncbi.nlm.nih.gov/pubmed/34709752
http://dx.doi.org/10.1002/ctm2.608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516365/
https://www.ncbi.nlm.nih.gov/pubmed/34709752
http://dx.doi.org/10.1002/ctm2.608

Ejemplares similares